Molecular Phenotyping of Reproductive Aging in Women with Subfertility and Infertility by Daria Yu. Gordienko² et al.
International 
Journal of 
Biomedicine 
International Journal of Biomedicine 2(3) (2012) 174-178
Clinical Research
Molecular Phenotyping of Reproductive Aging in Women with 
Subfertility and Infertility
Irina V. Sarvilina, PhD, ScD1*, Mikhail Yu. Gilyanovskiy, PhD1,
Daria Yu. Gordienko2
1Medical Centre «Novomeditsina», Rostov-on-Don, Russian Federation, 
2St. Petersburg State Budgetary Health Care Organization «Municipal Hospital #2»,
Saint-Petersburg, Russian Federation
________________________________________________________________________
Abstract
!ere is no scienti"c data on the molecular mechanisms of reproductive aging in women. !e purpose of the study is the development 
of molecular phenotypes of the aging in women with gynecologic pathology of reproductive and post-reproductive periods. !e 
present study included 90 women with subfertility of varying degrees of severity and infertility. All the patients were divided into 
three groups: I group (n=30) included patients with a weak degree of subfertility; II group (n=30) with middle and high degree of 
subfertility; III group (n=30) with clinical infertility. All the patients underwent the routine diagnosis of the sub- and infertility. 
Molecular phenotyping of blood serum and cervicovaginal #uid processed with methods in proteomics: the prefractionation, 
the separation of proteins with standard sets, MALDI-TOF-MS/MS. Bioinformatics analysis of the molecules in the biosamples 
was based on the integrated database «Bioinformatic Harvester». Statistical analysis of the survey data was performed using the 
so$ware «Statistica 7.0». Proteomic analysis helps in the detection of di%erences in the component composition of the serum 
proteins and CVF in women with subfertility of varying degrees of severity and infertility compared with the control group of 
fertile women. We have data on the universal molecular pathways of the development of reproductive aging in women with 
subfertility and infertility. IJBM 2012; 2(3):174-178. © 2012 International Medical Research and Development Corporation. All 
rights reserved.
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Introduction
!e  purpose  of  this  study  is  the  development  of 
molecular phenotypes of aging in women with a gynecologic 
pathology of the reproductive and post-reproductive periods.
!e  concept  of  «the  aging  of  a  person»  is  closely 
connected  with  concepts  of  «reproductive  health»  and 
«reproductive  aging».  !e  main  clinical  phenotypes  of 
reproductive aging in the female organism are connected with 
the development of gynecological diseases and conditions, 
including uterine "broid tumors, ovarian cysts, polycystic 
ovary syndrome, endometriosis in women of reproductive 
age,  in#ammatory  diseases  of  the  female  genitals  and 
menstrual  disorders  among  young  girls,  miscarriage  and 
other complications of pregnancy and childbirth, subfertility 
and  infertility,  oncological  pathology  in  women,  diseases 
pertinent  to  women  during  pre-  and  post-menopause, 
including  several  other  female  reproductive  system 
abnormalities [1].
Reproductive  aging  of  the  female  organism  in 
demographic researches is presented by indicators such as 
birth rate, mortality, the birth of a child in middle age, and 
the time prior to pregnancy (TTP). In the 21st century, two 
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birth rate: the reduction of the number of children per family 
and the displacement of the period of childbirth in women 
to a later age. !e success of the birth of the second child by 
a woman until 40 years, decreases as a rule, correlating with 
the progress of the processes of subfertility and infertility, as 
clinical phenotypes of reproductive aging.
Today,  some  molecular  interactions  in  the 
mechanism of human aging have been identi"ed. !e "elds 
of  female  reproductive  biology  best  studied  by  applying 
proteomics,  include  gynecological  cancers,  endometriosis 
and infertility [2, 3]. !ere is no scienti"c data about the 
molecular mechanisms of reproductive aging in women. !e 
creation of the database of new intermolecular interactions 
and molecular targets for subsequent development of new 
drugs for the prevention of reproductive aging in women is 
becoming highly relevant.
Material and Methods
!e present study included 90 women with subfertility 
of varying degrees of severity and infertility, according to the 
WHO criteria (1996), data of Habbema J. et al., and the value 
of TTP. !e control group consisted of 30 women based on 
the next criteria, which included women with two or/and 
more safe pregnancies within a year of sexual activity without 
contraception. !e women of the control group, included 
those with three or less pregnancies with no spontaneous 
abortions, although with four and more pregnancies they 
could have had spontaneous abortion. !e average age of the 
women with subfertility and infertility was 36±1.2 years of 
age, whereas the women with fertility in the control group 
were  35±1.1  years  of  age.  All  the  patients  were  divided 
into three groups: I group (n=30) included patients with a 
weak degree of subfertility, TTP=6 unsuccessful cycles; II 
group (n=30) with middle and high degree of subfertility, 
TTP=12  unsuccessful  cycles;  III  group  (n=30),  TTP=48 
months, with clinical infertility. All the patients underwent 
the  routine  diagnosis  of  infertility,  including,  total  and 
special gynecological examination; ultrasound examination 
of the female pelvic organs; determination of blood group 
and  Rh-factor;  complete  blood  count;  blood  tests  for 
syphilis,  HIV,  hepatitis  В  and  С;  the  study  of  biocenosis 
of  the  urethra,  vagina  and  cervix;  hysterosalpingoscopy 
and  laparoscopy  on  indications;  endometrial  biopsy; 
bacteriological examination and polymerase chain reaction 
of the urethral and cervicovaginal secretions; cervical smear 
tests; the de"nition of concentrations of follicle-stimulating 
hormone,  luteinizing  hormone,  estradiol,  prolactin, 
testosterone,  cortisol,  progesterone,  triiodothyronine, 
thyroxine, thyrotropin, somatotropin (ADVIA CENTAUR, 
Bayer  Diagnostics,  Germany);  the  detection  of  antisperm 
antibodies  and  antiphospholipid  antibodies;  screening 
for  infections  (Chlamydia  trachomatis,  Ureaplasma 
urealyticum, Mycoplasma genitalium, Herpes simplex virus, 
Cytomegalovirus,  Toxoplasma  gondii,  Rubella  virus);  the 
typing of HLA-А, -B, -C, -DR-antigens of lymphocytes of 
the pair; the study of genetic factors of habitual miscarriage 
and risks (G20210A prothrombin gene mutation, factor V 
G1691A  gene  mutations,  MTHFR  C677T  gene  mutation; 
ICycler  IQ-5,  BioRad,  USA).  Molecular  phenotyping  of 
biosamples (blood serum, CVF) processed with methods in 
proteomics: the prefractionation, the separation of proteins 
with standard sets (MB-HIC C8 Kit, MB-IMAC Cu, MB-
Wax Kit, «Bruker», USA), matrix-assisted laser desorption-
ionization  time-of-#ight  mass  spectrometry  (MALDI-
TOF-MS/MS,  Ultra#ex  II,  «Bruker»,  USA).  !e  partially 
identi"ed  sequences  were  then  submitted  to  «BLAST 
protein-protein»  and  screened  against  the  Homo  sapiens 
Swissprot database to check if this identi"cation matched the 
MASCOT-identi"cation  (Matrix  Science).  Bioinformatics 
analysis of the molecules in the biosamples was based on the 
integrated  database  “Bioinformatic  Harvester”  (Karlsruhe 
Institute of Technology, Germany). !e data of the molecular 
interactions and functional features of proteins were received 
with STRING 8.1 and STITCH databases. Statistical analysis 
of  the  survey  data  was  performed  using  the  so$ware 
«Statistica 7.0».
Results
!e study revealed several forms of female subfertility 
and  infertility,  signi"cantly,  endocrine  subfertility  and 
infertility, associated with the violation of ovulation (32%); 
Fallopian tube subfertility and infertility (28%); gynecological 
diseases as the causes of the subfertility and infertility (25%); 
immune subfertility and infertility (1%); and unexplained 
subfertility and infertility (14%).
!e compatibility was for one antigen HLA-DQ in 
14 out of 90 pairs (15.5%) with subfertility (4 pairs; 4.4%) 
and clinical infertility (10 pairs; 11.1%), for HLA-В - in 21 
out of 90 pairs (23.3%) with subfertility (9 pairs; 10%) and 
clinical infertility (12 pairs; 13.3%). Combinations for HLA 
in infertility were found in 35 out of 90 pairs (38.9%).
Factor V G1691A gene mutations were heterozygous 
in two women with subfertility and four women with clinical 
infertility, and in one woman of the control group. G20210A 
prothrombin  gene  mutation  has  not  been  identi"ed.  !e 
analysis of MTHFR C677T gene mutation rare allele 677T 
was found in 21 women of I group (70%): in homozygous 
- in 4 women (13.3%), in the heterozygous – in 17 women 
(56.7%); in 30 women of II group (100%): in homozygous - 
in 5 women (16.7%), in heterozygous – in 25 women (83.3%); 
in 30 women of III group (100%): in homozygous - in 7 
women (23.3%), in heterozygous – in 23 women (76.7%); in 
7 women of the control group (23.3%): in homozygous - in 
2 women (66.7%), in heterozygous – in 5 women (16.7%). 
Proteomic analysis helps in the detection of di%erences 
in the component composition of the serum proteins and 
cervicovaginal  #uid  (CVF)  in  women  with  subfertility  of 
varying degrees of severity and infertility compared with the 
control group of fertile women (Table 1, 2).
Bioinformatics  analysis  revealed  the  presence  of 
molecules,  which  are  the  participants  of  the  universal 
pathways of reproductive aging in women and the molecular 
interactions involved.
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Discussion
Proteomic  analysis  has  revealed  an  increase  in 
the  absolute  number  of  women  with  protein  expression 
performing certain biological functions and having various 
localizations in the intra - and extracellular spaces (Table 1, 
2).
Molecules was seen to interact among themselves and 
with other molecules as participants of universal pathways 
in reproductive aging in women, which is the chief cause 
for  subfertility  and  infertility:  the  hormonal  signaling 
pathway (insulin and insulin-like signaling, growth hormone 
signaling, steroid signaling, Klotho signaling, AC5, TGFβ), 
nutrient sensing and signaling pathway (sirtuin deacetylases, 
AMP-activated  protein  kinase,  TOR  and  translation 
signaling,  FOXA/PHA-4  transcription  factor  signaling, 
NRF1/SKN-1 signaling), mitochondria and ROS signaling 
(electron-transport chain signaling, stress-induced protein 
kinases:  JNK  and  MST-1),  genome  surveillance  pathways 
(tumor suppressors and antagonistic pleiotropy).
Each  protein  molecule  in  the  functional  group 
interacts  with  other  protein  molecules.  For  example,  the 
Table 1
Qualitative pro!le of serum proteins in women with the subfertility, infertility and in control group of fertility women
Protein name
n (the number of women with the expression of the 
serum protein) Functional process
(source: Bioinformatic 
Harvester, KIT, Germany)
Control 
group
(n=30)
I 
group
(n=30)
II
group
(n=30)
III
group
(n=30)
1MW,
2Dа
1 Beta-defensin 2  30 12 10 2 7820
Immunity and defense, 
nucleoside, nucleotide and 
nucleic acid metabolism
2 Metalloproteinase inhibitor 1  0 7 24 30 23794
Developmental processes, 
protein metabolism and 
modi"cation
3 Cystatin-C 2 15 18 28 13300 Protein metabolism and 
modi"cation
4 Apolipoprotein A-II  0 6 23 30 11175
Lipid, fatty acid and steroid 
metabolism, transport
5 Apolipoprotein B-100 1 5 14 30 515605
Lipid, fatty acid and steroid 
metabolism, transport
6 Glucose-6-phosphate 
isomerase
30 21 14 3 59991 Carbohydrate metabolism
7 Glycodelin  1 15 18 30 16361 Developmental processes
8
Macrophage migration 
inhibitory factor 0 22 26 30 12476 Immunity and defense
9 Metalloproteinase inhibitor 2 1 25 29 30 72000 Protein metabolism and 
modi"cation
10
Carcinoembryonic antigen-
related cell adhesion molecule 
8 precursor
0 0 14 30 38154
Cell adhesion, signal 
transduction
11 Repetin 0 20 22 27 90731
Cell proliferation 
and di%erentiation, 
developmental processes
12 Kallikrein-14 2 17 22 26 29122 Protein metabolism and 
modi"cation
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Table 2
Qualitative pro!le of proteins of cervicovaginal "uid in women with the subfertility, infertility and in control group
Protein name
n (the number of women with the expression of the 
protein in CVF1) Functional process
(source: Bioinformatic 
Harvester, KIT, 
Germany)
Cellular 
localization Control 
group
(n=30)
I group
(n=30)
II group
(n=30)
III
group 
(n=30)
2MW, 
3Dа
1
Putative tropomyosin 
alpha-3 chain-like 
protein
15 27 28 24 26269 Cell structure and 
mobility Cytoplasm
2
Voltage-dependent P/Q-
type calcium channel 
subunit alpha-1A
12 16 27 26 282365
Muscle contraction, 
neuronal activities, 
transport
Nucleus
3 Actin-related protein 
2/3 complex subunit 2
30 22 6 4 40950
Protein metabolism 
and modi"cation, cell 
structure and mobility
Cytoskeleton
4 Histone H2B type 1-K 30 10 8 2 13890
Immunity and defense, 
nucleoside, nucleotide 
and nucleic acid 
metabolism
Nucleus
5 Probable phospholipid-
transporting ATPase VB
20 25 25 27 165391
Lipid, fatty acid and 
steroid metabolism,
transport
Membrane
6 Hemoglobin subunit 
delta 8 12 14 18 16055
Blood circulation and 
gas exchange,
transport
Cytoplasm
7 Tropomyosin beta chain 30 27 25 23 32851
Cell structure and 
mobility,
developmental processes, 
muscle contraction
Cytoskeleton
8 Clathrin light chain B 5 8 21 30 35000 Intracellular protein 
traZc
Golgi
Apparatus
9 Carboxypeptidase M 0 2 4 30 36520
Protein metabolism and 
modi"cation Membrane
10
B-Raf proto-oncogene 
serine/threonine-
protein kinase
0 4 9 30 84437
Apoptosis, cell 
proliferation and 
di%erentiation, 
oncogenesis, signal 
transduction
Membrane
11
Small proline-rich 
protein 2E 12 16 17 21 7855
Developmental 
processes, cell 
proliferation and 
di%erentiation
Cytoskeleton
12 Peroxiredoxin-6 3 23 28 28 27100 Immunity and defense Cytoplasm
13
Carnitine O- palmitoyl-
transferase 2, 
mitochondrial
6 15 27 24 73777
Amino acid metabolism, 
lipid, fatty acid and 
steroid metabolism
Envelope
14 Nesprin-2 1 18 26 26 796442 Cell structure and 
mobility
Nucleus
15 Toll-like receptor 7 
precursor 5 12 17 28 120922
Developmental 
processes, signal 
transduction
Membrane
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molecular  interactions  of  glycodelin  or  progestagen-
associated endometrial protein, are presented (Fig. 1). !e 
concentration of glycodelin rises in the serum of infertile 
women with abnormal tubes compared with fertile controls. 
Conclusion
We identi"ed potentially new biomarkers that di%er 
among women with subfertility and infertility and that could 
aid in developing a noninvasive, serum-based diagnostic test. 
!is study is the "rst step in the identi"cation of potentially 
new  biomarkers  of  reproductive  aging  in  women.  Future 
identi"cation  of  the  proteins  and  further  validation  in  a 
second population is needed before these "ndings can be 
applied in clinical practice.
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Figure 1
Molecular interactions of progestagen-associated endometrial protein (glycodelin) (STRING 8.1 database).
Notes:  PAEP - progestagen-associated endometrial protein (glycodelin); TNFRSF14 - tumor necrosis factor receptor superfamily, 
member 14; DARC - Du$y blood group, chemokine receptor; GH1 - growth hormone 1; PVRL1 - poliovirus receptor related 1; GYPC 
glycophorin C; PVRL2 - poliovirus receptor-related 2; FUT5 - fucosyltransferase 5; GDF7 - growth di$erentiation factor 7; GDF5 - 
growth di$erentiation factor 5; KIFAP3 - kinesin-associated protein 3.